Vaccination with inactivated SARS-CoV-2 vaccine TURKOVAC induces durable humoral and cellular immune responses up to 8 months
BackgroundThe rapid spread of the SARS-CoV-2 virus has led to a global health crisis, necessitating swift responses in medical science, mainly through vaccination strategies. While short-term vaccine effectiveness is evident, immune protection’s long-term effects and duration remain incompletely und...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Frontiers Media S.A.
2025-04-01
|
| Ráidu: | Frontiers in Medicine |
| Fáttát: | |
| Liŋkkat: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1524393/full |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
